RSVpreF vaccine prevents RSV-associated illness in adults aged 60+
1. In this randomized controlled trial, respiratory syncytial virus prefusion F protein-based vaccine (RSVpreF) prevented RSV-associated lower respiratory tract illness ...
Tag: pulmonology
Sotatercept improves outcomes in patients with pulmonary arterial hypertension
1. Among patients on stable therapy for pulmonary arterial hypertension (PAH), sotatercept resulted in a significant improvement in six-minute walk ...
Molnupiravir and nirmatrelvir-ritonavir reduce COVID-19 mortality in hospitalized patients
1. In this trial emulation study, molnupiravir and nirmatrelvir-ritonavir reduced all-cause mortality in vaccinated and unvaccinated hospitalized patients with coronavirus ...
Symptom and viral relapse more common in COVID-19 patients without antiviral treatment
1. In this retrospective analysis, symptom and viral rebound occurred in almost one-third of coronavirus disease 2019 (COVID-19) patients that ...
Bedaquiline-linezolid regimen noninferior to standard treatment for tuberculosis
1. In this randomized control trial, an eight-week bedaquiline-linezolid regimen was noninferior to standard 24-week treatment for tuberculosis. 2. The ...
Black patients with pulmonary fibrosis may have worse outcomes compared to other populations
1. In this retrospective cohort study, Black patients with pulmonary fibrosis (PF) were found to have a younger age of ...
![Macitentan better than placebo for preventing progression of pulmonary arterial hypertension [SERAPHIN Trial]](https://www.2minutemedicine.com/wp-content/uploads/2013/08/ca68dc0329bef0b42ccae7b6656a0f_gallery-350x250.jpg)
Sotorasib superior to docetaxel for treatment of KRASG12C-positive non-small-cell lung cancer
1. Patients allocated to the sotorasib group reported increased progression-free survival compared to the docetaxel group. 2. Sotorasib was generally ...
Ad26.RSV.preF-RSV vaccination prevents RSV infection in older adults
1. In this randomized controlled trial, vaccination with Ad26.RSV.preF-RSV preF protein was associated with significantly reduced respiratory syncytial virus (RSV) ...
BNT162b2 COVID-19 vaccine safe and efficacious in young children
1. A three-dose series of BNT162b2 was efficacious in eliciting an immune response and protecting children between six months and ...
RSV prefusion F protein vaccine is safe and effective in preventing RSV infection
1. A single dose of the respiratory syncytial virus (RSV) prefusion F protein vaccine had an acceptable safety profile in ...
